Public Sector Pension Investment Board Travere Therapeutics, Inc. Transaction History

Public Sector Pension Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$17.82 - $22.89 $4.17 Million - $5.36 Million	-234,000 Reduced 72.9%	87,000 $1.96 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $3.08 Million - $4.37 Million	167,000 Added 108.44%	321,000 $6.75 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $3.53 Million - $4.41 Million	154,000 New	154,000 $3.8 Million
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $8.48 Million - $11 Million	-359,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $2.95 Million - $3.77 Million	121,000 Added 50.84%	359,000 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $1.39 Million - $2.68 Million	107,000 Added 81.68%	238,000 $5.77 Million
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $1.85 Million - $3.46 Million	131,000 New	131,000 $1.91 Million
Q1 2021 May 14, 2021	SELL	$23.37 - $31.77 $1.22 Million - $1.65 Million	-52,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $996,840 - $1.45 Million	52,000 New	52,000 $1.42 Million

199

85.2M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.35B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.